United StatesLevocarnitine Injection, USP, 1 g/5 mL (200 mg/mL) in 5 mL single‑dose vials (NDC 0517-1045-01) distributed by American Regent, Inc., lots 24159N0C0 (exp. June 30, 2026) and 25193N0C0 (exp. July 31, 2027). The product is being recalled nationwide in the U.S. because the vials may be missing their labels.
What's being recalled
Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For intravenous use, Rx Only, American Regent, Inc., Shirley, NY 11967. NDC: 0517-1045-01
Recalling firm: American Regent, Inc., New Albany, OH, United States.
How to identify it
Lot 24159N0C0, Exp. June 30, 2026 Lot 25193N0C0, Exp. July 31, 2027
The hazard
Labeling: Missing Label
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)